Immunity against pathogenic challenge requires the engagement of pathogen origin molecular signatures by innate immune sensors that are expressed on various immune and non-immune cells. This microbial pathogen primarily includes various bacteria or viruses. The sensing of viruses leads to the complex interaction of innate immune sensors, which consist of families of evolutionarily conserved germline-encoded molecules known as pathogen recognition receptors (PRRs). This family includes RIG-I-like receptors (RLRs), Toll-like receptors (TLRs), NOD-like receptors (NLRs) 1 and DNA sensors (cGAS, IFI16, DAI and AIM2). 2 The cytoplasmic helicases RIG-I and MDA5 are the key innate sensors that detect viral genomic RNAs. A few Toll-like receptors (TLRs),  such as TLR3, TLR7, TLR8 and TLR9,  are To avoid immunopathology, the sensing of viruses and signaling pathways is tightly regulated at the transcriptional and translational levels and determines the duration and magnitude of immune responses to ensure viral clearance and immune homeostasis. Recent years have witnessed such modes of regulation; for example, miRNAs have emerged as one of the key players to regulate gene expression by targeting the 3′-untranslated regions (UTR) of mRNA, resulting in degradation via cleavage, translational repression and deadenylation. 7 Similarly, phosphorylation and ubiquitination are wellcharacterized post-translational modifications that also control the intensity of the immune responses. Moreover, the anti-viral innate immune system is equipped with several molecules to down-regulate the innate anti-viral response. The downregulation may be caused by direct interactions or posttranslational modifications, such as peptidyl-prolyl isomerase PIN1, FoxO1 and TRIM21, which dampen the activation of IRF3 (Table 1) . [8] [9] [10] [11] [12] [13] [14] [15] [16] Given the vital roles of IRF3 in the expression of an anti-viral state, via the production of pro-inflammatory molecules and type I and III IFNs, research is now focused primarily on identifying novel regulators (positive and negative), with the aim of finding new therapeutic targets during viral infection and combatting several autoimmune diseases. 5 In a recent article published in Nature Immunology, Wang et al. 17 identified a molecule known as YAP (Yes-Associated Protein 1), which was previously reported to be involved in cellular growth, repair and homeostasis and to be modulated by the hippo signaling pathway. Here, Wang et al. 17 reported a novel function of YAP in innate antiviral immunity. Using in vitro and in vivo studies, the authors found that the transcriptional effector YAP protein functions as a negative regulator of innate immune responses to different RNA and DNA viruses by blocking the dimerization and subsequent nuclear translocation of IRF3 during viral infection. Moreover, YAP is phosphorylated at serine 403 (S403) by IKKε and is subjected to lysosome-mediated proteasomal degradation upon virus infection, which in turn abolishes the YAP-mediated restriction of anti-viral responses (Figure 1 ). This study defined the important machinery involved in the tight regulation of type I IFN production, thereby casting new light on the mechanism of type I IFNs regulation by cellular factors. Although the findings of this study have provided new mechanistic insights into the regulation of the innate immune signaling pathway, a series of concerns have also been raised in type I IFN biology. First, what is the purpose of the existence of multiple negative regulators of IRF3 to suppress anti-viral responses? Second, are these regulations cell-type, virus or stimuli specific? Third, do the various regulators ensure appropriate regulation during the failure or dysregulation of any of the negative regulators? Most likely, the spatiotemporal differences that allow these proteins to suppress IRF3 by a different mode of editing are coordinated in a highly complementary manner to warrant viral clearance and immune homeostasis.
Recently, Zhang et al. 18 reported a previously unrecognized role of YAP/ TAZ in the attenuation of innate immune sensing by degrading TBK1, which was relatively consistent with the results of this study. Thus, in future studies, it will be interesting to determine whether these hippo signaling components regulate the degradation of the host's immune components (TBK1 and IRF3) together or in a stimuli-dependent manner. Second, is this YAP-mediated virus-induced degradation of TBK1-IRF3 a virus-specific phenomenon? The answers to these key questions may reveal the complexities of homeostatic control of anti-viral innate immune signaling pathways and may provide new insights for the identification of novel therapeutic targets.
